|
[影像学随访]
肝癌TACE的随访
日期:2022-02-23 00:42:49
点击:99
TACE术后病人的随访包括临床和影像 BCLC staging and treatment strategy, 2012 Forner, et al. Lancet. 2012 Mar 31;379(9822):1245-55. 为什么说TACE是中期肝癌的标准治疗 *P values refer to cumulative meta-analysis of five and six studies, respecti ...
[HAIC技术]
HAIC技术
日期:2022-02-13 22:13:20
点击:99
尽管标准化的HAIC技术是评估HAIC安全性和疗效的重要因素,但HAIC技术的异质性仍然是评价这一技术的争议之一。 许多HAI化疗技术可以通过放置一个输液港-导管系统来进行。 在过去,输液导管是通过剖腹手术植入的,但患者暴露于与剖腹手术和全身麻醉相关的风险。...
[肝动脉灌注化疗]
肝癌肝动脉灌注化疗
日期:2022-02-13 19:50:42
点击:99
肝动脉灌注化疗,Hepatic artery Infusion Chemotherapy,简称HAIC 按肿瘤药物对肿瘤的生物学效应包括 1. 肿瘤对药物的敏感性 2. 肿瘤与药物的接触时间 3. 肿瘤与药物的接触浓度 2020年《中国临床肿瘤学会(CSCO)原发性肝癌诊疗指南》指出以下类型患者推荐...
[HAIC单治疗]
HAIC
日期:2022-02-10 00:59:23
点击:99
简介 Hepatic artery infusion chemotherapy (HAIC) is a treatment modality for advanced hepatocellular carcinoma (HCC). 肝动脉输注化疗(HAIC)是治疗晚期肝癌(HCC)的一种治疗方式。 HAIC entails infusing chemotherapeutic agents directly into hepat...
[HAIC联合治疗]
基于HAIC的联合治疗
日期:2022-02-10 00:39:13
点击:99
The following characteristics of HAIC render it a suitable candidate for combination with other antineoplastic agents for advanced HCC: it is associated with fewer systemic adverse events compared with intravenous chemotherapy, and its cyt...
[术前准备]
术前准备
日期:2021-12-31 13:54:16
点击:99
参与此项治疗的介入医生、外科医生和肿瘤内科医生应详知HAIC(经动脉灌注化疗)方法,原理,相关并发症和病人管理。 Work-upPreoperative imaging included cross-sectional imaging with computed tomography (CT) and/or magnetic resonance imaging (MRI)...
[缺乏进行试验的行业激励措施]
HAIC研究潜在障碍:缺乏行业激励
日期:2021-12-28 21:43:21
点击:99
Lack of Industry Incentive for Conducting Trials 开展试验缺乏行业激励 The patents for the main chemotherapeutic agents used in HAIC, including cisplatin, oxaliplatin, 5-FU, and epirubicin, have expired, thus weakening the motivation for th...
[缺乏技术标准]
HAIC研究潜在障碍:技术标准化不足
日期:2021-12-28 13:45:34
点击:99
Insufficient Technical Standardization Techniques and protocols for HAIC have yet to be standardized. HAIC的技术和方案尚未标准化。 The efficacy and safety of HAIC depend substantially on the quality of vascular redistribution. HAIC的有效性...
[重复导管 vs 动脉港]
HAIC研究潜在障碍:重复导管术 vs 药盒置入
日期:2021-12-28 13:34:36
点击:99
Two different percutaneous arterial access approaches have been used for HAIC: the first approach entails the use of implantable port-catheter systems, and the second approach involves repeated hepatic artery catheterization. 两种不同的经...
[多种化疗方案]
HAIC研究的潜在障碍:多种化疗方案
日期:2021-12-28 11:54:22
点击:99
A standard chemotherapy regimen for HAIC has yet to be established, increasing the challenge of interpreting trial results. HAIC的标准化疗方案尚未建立,这增加了解释试验结果的挑战。 Cisplatin and 5-FU were the most commonly used chemotherap...
背景 :COLLISION 试验【 Robbert 2018 】:是结直肠肝转移手术与热消融术比较的-一项...
结肠癌肝转移介入治疗的历史 结肠癌肝转移介入治疗的现状 目前介入治疗在结肠癌肝转移...
TACE术后病人的随访包括临床和影像 BCLC staging and treatment strategy, 2012 Forne...
肿瘤病理学发源于19世纪后叶的欧洲。自有肝癌病理分类的100多年以来在此领域内研究的...
肝癌的实验室检查在肝癌诊断中面临两个角色。肝癌的早期诊断的筛查或肝癌的筛查和肝癌...
栓塞治疗作为肿瘤治疗手段之一,被报道应用于全身多处部位的肿瘤。这其中包括肾癌、肺...